— Know what they know.
Not Investment Advice

XOMAP NASDAQ

XOMA Royalty Corporation
1W: +0.0% 1M: +0.3% 3M: -4.4% YTD: -7.9% 1Y: -0.4% 3Y: +22.3% 5Y: +36.5%
$24.98
Last traded 2026-07-21 — delisted
NASDAQ · Healthcare · Biotechnology · $301.3M mcap · 12M float · 0.026% daily turnover · Short 57% of daily vol

📊 Key Metrics

TTM
$36M
Revenue
-15.6% YoY
$34M
Net Income
+1282.6% YoY
$7M
Free Cash Flow
+199.2% YoY
92.7%
Gross Margin
-3.9%
Op. Margin
36.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE34.2%
ROA14.0%
ROIC3.5%

Valuation

P/E15.1
P/B2.6
EV/EBITDA15.0

Leverage

Debt/Equity1.10
Current Ratio3.59
Interest Cov.2.1x

Quality Scores

Piotroski F5/9
Altman Z-3.72
Beneish M-1.61

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms